Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Riverwater Partners Small Cap Strategy. This analysis is provided for institutional research purposes only and is not investment advice.
SOURCE UNAVAILABLE
Fund Returns
Positioning StanceNEUTRAL
Market CapSmallCap
GeographyUS
Digest Analysis
Quick Take
"Riverwater's Small Cap strategy trailed the Russell 2000's 21% Q2 surge as markets rewarded speculation over quality. Energy stock selection drove outperformance through services positioning, while healthcare lagged as speculative biotech rallied."
Executive Summary
Riverwater Partners' Small Cap strategy underperformed the Russell 2000's 21% surge in Q2 2026, as the market rewarded lower-quality, high-beta stocks while the manager's quality bias and healthcare positioning created headwinds. The quarter was defined by an accelerating AI buildout and a geopolitical oil and gas supply shock, though a mid-quarter ceasefire announcement reversed energy and materials weakness. Energy was the best-performing sector through deliberate positioning toward gas compression and services rather than commodity producers, with holdings gaining 12% versus a 10% benchmark decline. Top contributors included StoneX (up 47%), PDF Solutions (up 52%), and Digi International (up 55%). Healthcare was the largest detractor as speculative biotechnology surged 25% while the manager's profitable holdings declined modestly, reflecting the cost of avoiding pre-revenue biotech. The manager initiated seven new positions including NetScout Systems, Middleby, Lifeway Foods, Werner Enterprises, Oceaneering International, Kaiser Aluminum, and Stevanato Group, while trimming winners and exiting Perella Weinberg, Talkspace, and others. Looking forward, the manager is cautiously optimistic, anticipating a rotation into higher-quality businesses as speculative AI trades unwind, while increasing consumer staples exposure and positioning for a broader healthcare sector rotation.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.